| 000 | 01906 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518101059.0 | ||
| 264 | 0 | _c20200715 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1423-0232 | ||
| 024 | 7 |
_a10.1159/000505486 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNovo, Giuseppina | |
| 245 | 0 | 0 |
_aCardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience. _h[electronic resource] |
| 260 |
_bOncology _c2020 |
||
| 300 |
_a445-451 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xchemically induced |
| 650 | 0 | 4 |
_aDasatinib _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aGastrointestinal Stromal Tumors _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xadverse effects |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aPulse Wave Analysis |
| 650 | 0 | 4 |
_aPyridazines _xadverse effects |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDi Lisi, Daniela | |
| 700 | 1 | _aBronte, Enrico | |
| 700 | 1 | _aMacaione, Francesca | |
| 700 | 1 | _aAccurso, Vincenzo | |
| 700 | 1 | _aBadalamenti, Giuseppe | |
| 700 | 1 | _aRinaldi, Gaetana | |
| 700 | 1 | _aSiragusa, Sergio | |
| 700 | 1 | _aNovo, Salvatore | |
| 700 | 1 | _aRusso, Antonio | |
| 773 | 0 |
_tOncology _gvol. 98 _gno. 7 _gp. 445-451 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000505486 _zAvailable from publisher's website |
| 999 |
_c30914802 _d30914802 |
||